Patents matching “recombinant”

AU 2021290177

A recombinant Modified Vaccinia Virus Ankara (MVA) vaccine against coronavirus disease

BAVARIAN NORDIC AS [DK] · Granted Jan 19, 2023 · Expires Jan 14, 2043

US 11542538

Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates

Northwestern University · Granted Jan 3, 2023 · Expires Dec 29, 2042

US 11529395

Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

Takeda Pharmaceutical Company Limited · Granted Dec 20, 2022 · Expires Dec 15, 2042

US 11524987

Highly purified recombinant human insulin (RHI) API and methods of producing the same

Amphastar Pharmaceuticals, Inc. · Granted Dec 13, 2022 · Expires Dec 8, 2042

US 11512117

Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof

SOUTH CHINA AGRICULTURAL UNIVERSITY · Granted Nov 29, 2022 · Expires Nov 24, 2042

US 11492388

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

Takeda Pharmaceutical Company Limited · Granted Nov 8, 2022 · Expires Nov 3, 2042

US 11478517

Live attenuated recombinant HMPV with mutations in PDZ motifs of M2-2 protein, vaccine containing and use thereof

The Board of Regents of the University of Texas System · Granted Oct 25, 2022 · Expires Oct 20, 2042

US 11459360

Recombinant HIV-1 envelope proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

US 11401341

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11396540

Methods for making recombinant proteins

Coherus BioSciences, Inc. · Granted Jul 26, 2022 · Expires Jul 21, 2042

US 11332721

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a range of attenuation phenotypes

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 17, 2022 · Expires May 12, 2042

US 11305009

Recombinant virus with diminished latency and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 19, 2022 · Expires Apr 14, 2042

US 11299517

Recombinant vaccine against Marek's disease and Newcastle disease

The United States of America, as represented by the Secretary of Agriculture · Granted Apr 12, 2022 · Expires Apr 7, 2042

US 11273214

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 15, 2022 · Expires Mar 10, 2042

US 11254731

Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A

Takeda Pharmaceutical Company Limited · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11246947

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressive RP

Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum · Granted Feb 15, 2022 · Expires Feb 10, 2042

US 11197916

Lyophilized recombinant VWF formulations

Takeda Pharmaceutical Company Limited · Granted Dec 14, 2021 · Expires Dec 9, 2041

US 11191813

Lyophilized recombinant VWF formulations

Takeda Pharmaceutical Company Limited · Granted Dec 7, 2021 · Expires Dec 2, 2041

US 11191837

Recombinant VWF formulations

Takeda Pharmaceutical Company Limited · Granted Dec 7, 2021 · Expires Dec 2, 2041

US 11155804

Recombinant polypeptides comprising selenocysteine and method for producing the same

The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

US 11136356

Recombinant HIV-1 envelope proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

US 11104719

Recombinant clusterin and use thereof in the treatment and prevention of disease

The Board of Regents of the University of Texas System · Granted Aug 31, 2021 · Expires Aug 26, 2041

US 11084850

Recombinant prefusion RSV F proteins and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 10, 2021 · Expires Aug 5, 2041

US 11078257

Recombinant gram negative bacteria and methods of generating and utilizing same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 3, 2021 · Expires Jul 29, 2041